Angiogenesis, the formation of new capillaries from preexisting blood vesse
ls, is a multistep, highly orchestrated process involving vessel sprouting,
endothelial cell migration, proliferation, tube differentiation, and survi
val. Eicosanoids, arachidonic acid (AA)-derived metabolites, have potent bi
ologic activities on vascular endothelial cells. Endothelial cells can synt
hesize various eicosanoids, including the 12-lipoxygenase (LOX) product 12(
S)-hydroxyeicosatetraenoic acid (HETE), Here we demonstrate that endogenous
12-LOX is involved in endothelial cell angiogenic responses. First, the 12
-LOX inhibitor, N-benzyl-N-hydroxy-5-phenylpentanamide (BHPP), reduced endo
thelial cell proliferation stimulated either by basic fibroblast growth fac
tor (bFGF) or by vascular endothelial growth factor (VEGF), Second, 12-LOX
inhibitors blocked VEGF-induced endothelial cell migration, and this blocka
ge could be partially reversed by the addition of 12(S)-HETE. Third, pretre
atment of an angiogenic endothelial cell line, RV-ECT, with BHPP significan
tly inhibited the formation of tubelike/cordlike structures within Matrigel
. Fourth, overexpression of 12-LOX in the CD4 endothelial cell line signifi
cantly stimulated cell migration and tube differentiation. In agreement wit
h the critical role of 12-LOX in endothelial cell angiogenic responses in v
itro, the 12-LOX inhibitor BHPP significantly reduced bFGF-induced angiogen
esis in vivo using a Matrigel implantation bioassay, These findings demonst
rate that AA metabolism in endothelial cells, especially the 12-LOX pathway
, plays a critical role in angiogenesis.(Blood .2000;95:2304-2311) (C) 2000
by The American Society of Hematology.